A COMPANY which develops modern drugs from ancient Oriental medicines is close to signing the biggest biotech deal in Chinese history. Hutchison China MediTech (Chi-Med), controlled by the billionaire Sir Li Ka-shing, floated on the Alternative Investment Market last year to fund research into traditional Chinese cures for cancer and arthritis.
